Introduction
In an earlier investigation of the characteristics of growth hormone secretion in patients with Huntington's chorea (Phillipson & Bird, 1976) it was found that patients with this disorder had high fasting levels of growth hormone in plasma and abnormal hormone responses both to an oral glucose load and to intravenous insulin.
The present work investigates some of the consequences of these abnormalities in the same group of subjects.
Growth hormone is known to be involved in the release of free fatty acids from adipose tissue stores (Raben & Hollenberg, 1959) . In the first part of our study, therefore, we examined the blood glucose and plasma NEFA response to oral glucose and intravenous insulin in patients with Huntington's chorea and in control subjects. The results show marked abnormalities in plasma NEFA concentrations.
The influence of NEFA on the distribution of free and bound tryptophan has been extensively reviewed (Curzon & Greenwood, 1974) . This amino acid is particularly relevant as it appears to play a part in the control of S-hydroxytryptamine (serotonin) synthesis in the brain (Knott & Curzon, 1972; Biggio, Fadda, Fanni, Tagliamonte & Gessa, 1974; 
T. Phillipson and E. D. Bird 1974).
The chief effect of increased plasma NEFA concentration is to decrease the degree to which tryptophan is bound to plasma albumin (Curzon, Friedel, Kantamaneni, Greenwood & Lader, 1974) . Furthermore, the degree of plasma binding of tryptophan partly determines the amount of free tryptophan available for intracellular metabolism and synthesis of 5-hydroxytryptamine in brain. In addition to these factors, however, tryptophan entry into brain can be competitively inhibited by other neutral amino acids, notably the branchedchain amino acids leucine, isoleucine and valine (Fernstrom & Wurtman, 1972) . The ratio of tryptophan to these amino acids in plasma is therefore important in controlling the rate of tryptophan entry into brain (Fernstrom, Faller & Shabshelowitz, 1975) . T. L. Perry has shown that the concentrations of several plasma amino acids including leucine, isoleucine and valine are reduced in patients with Huntington's chorea (Perry, Hansen, Diamond & Stedman, 1969) . In the second part of the study we therefore present data on the concentrations of free and total tryptophan in plasma and of the amino acids which compete for the uptake of tryptophan into the brain.
Methods
Criteria used for the diagnosis of Huntington's chorea were a positive family history, progressive chorea and progressive dementia. Nine patients with the disease and nine age-and sexmatched control subjects were given a glucose tolerance test (100 g orally) followed by an insulin provocation test (0.1 i.u./kg, intravenously) the following day. None of the subjects was taking any drugs, with the exception of three control subjects (treated with dihydrocodeine, ethinyloestradiol and clonidine) and these three patients did not take any drugs on the day of the tests. None of the subjects was obese (i.e. greater than 15% over the ideal body weight) and none of the controls had a history of metabolic or endocrine abnormality. The mean age of the choreic group was 43 years and that of the control group 41 years. The mean weight of the control group was 66 kg and that of the choreic group 56 kg.
Patients had been eating their normal diets before the tests. After an overnight period of fasting, an indwelling cannula was inserted into a forearm vein and connected to a slowly running infusion of sodium chloride solution (154 mmol/l; saline). Both control and choreic groups received about the same volume of saline throughout the tests. The patient was then allowed to become accustomed to the experimental situation for a further 30 min, after which three base-line blood samples were withdrawn at -30, -15 and 0 min before either glucose or insulin was given. Blood was taken thereafter every 30 min for 4 h. Samples were kept at 4°C until centrifuged for 10 min at room temperature at lo00 g. Plasma was then separated and stored at -20°C until analysis. Glucose was assayed in whole blood on a Technicon Autoanalyser mark 2 by the standard Neocuproine method (AA11-02).
NEFA were assayed by a colorimetric micromethod based on the formation of NEFAcopper soaps (Laurel1 & Tibbling, 1967). Total and free tryptophan were determined by the method of Denckla & Dewey (1967) . Values for free tryptophan obtained by this method were found to be reproducibly lowered by the increase in pH of the plasma from pH 7.9 to about pH 8.1 which occurred before assay. The characteristics of this change were studied and a correction was made to obtain the true free tryptophan value at pH 7.4 (G. Curzon, personal communication) . Amino acids were assayed on a Durrum D500 Automatic Amino Acid Analyser after precipitation of plasma proteins with equal volumes of trichloroacetic acid (100 g/l). Plasma albumin was assayed by a Bromocresol Green dye-binding method.
Consent for the studies was obtained both from the patients and control subjects, and from the Ethical Committee of the Hospital.
Significance of results was assessed by the use of Student's t-test.
Results
Plasma glucose ( Fig. 1) Fasting glucose concentrations before both tests were similar in both the choreic group and control subjects. In the glucose tolerance test, the rise in glucose was slightly, but not significantly, faster in the choreic group compared with control subjects, but the rest of the plasma glucose curve was the same in both groups. In the insulin provocation test there were no significant differences between the groups. Plasma NEFA (Fig. 2) Fasting NEFA concentrations were significantly higher in the choreic group both before the glucose tolerance test and the insulin provocation test (P ~0 . 0 1 ) for all mean fasting values of NEFA. However, in the glucose tolerance test, 1 h after oral glucose, NEFA concentrations in the choreic group were not significantly different from in control subjects and remained so for a further 2 h. Thereafter NEFA in the choreic group increased to significantly higher concentrations than in control subjects, as they approached their high fasting values again.
In the insulin tolerance test, the differences between fasting NEFA in choreic and control groups were maintained throughout the whole test. All mean values for choreic patients were significantly different from control subjects (PcOX)O5 for all mean values). Furthermore, the degree of difference was maintained throughout the test, the mean values for choreic patients being three to four times higher than control values at each time-point. Total tryptophan (Fig. 3) There were no marked differences between choreic and control groups in either the fasting total tryptophan concentrations or the response to either glucose or insulin. Indeed, theresponses to the different stimuli were quite similar, the total tryptophan tending to fall during the course of both tests, the maximum fall in the glucose tolerance test being 28% at 34 h and 34% at 3 h in the insulin test. There was a slight tendency for the rate of fall to be greater in the control subjects than in choreic patients in both tests.
Free tryptophan (Fig. 4) In both the glucose tolerance test and insulin test, fasting free tryptophan concentrations in the choreic group were significantly lower than in control subjects for all the mean fasting values (P<O.o05 for all points). In the disease group, the mean reduction in free tryptophan for all fasting values was 43%. As with the NEFA results, the differences between the two groups was either reduced or abolished after oral glucose, but were maintained significantly throughout the insulin test. In the glucose tolerance test, there was a sharp fall in free tryptophan in control subjects compared with a slower fall in the choreic group. In both groups intravenous insulin caused a sharp fall in free tryptophan, followed by a return of free tryptophan to normal concentrations at the time when NEFA values were rising sharply. Throughout the test, the control values were between 1.5 and 2.0 times those of the disease group. Thus the shape of the curve was identical in the two groups after insulin, but differed after glucose.
A line with the best fit for each group of points was calculated by linear regression analysis. The value obtained for r was 0.71 in control group and 0.74 in the choreic group. These figures show that there is a relationship between free tryptophan and NEFA in both groups, and that the relationship is significant at the 1% level. Both lines intercept they axis at approximately the same point. However, the slope of the lines appears quite different, so that increasing NEFA values cause very little change in free tryptophan in the choreic group when compared with the control group.
Relation between NEFA and plasma free tryptophan (Fig. 5 ) Amino acid analyses (Table 1 ) The values for the mean NEFA concentraThese analyses were performed on a separate tions at each time-point in both tests were group of control subjects and choreic patients plotted against the values for the mean free from those studied for the glucose tolerance and tryptophan at each corresponding time-point. insulin provocation tests. In this case eight controls and eight age-and sex-matched patients with Huntington's chorea were studied and plasma was obtained by venepuncture after an overnight fast. None of the control subjects had a history of endocrine or metabolic abnormalities and none of the subjects was being treated with drugs. The procedure for obtaining plasma was as described in the Methods section. Significant reductions were seen in the early morning fasting plasma concentrations of leucine (1 1 %), isoleucine (30",) and valine (19%). Tyrosine and phenylalalanine concentrations, however, were not affected significantly.
Plasma albumin
Early morning fasting plasma albumin concentrations were measured in the plasma samples used for the amino acid analyses. The mean value for the control group was 46.2 k 1.7 g of albumin/l compared with 45.5 f 0 . 9 g/l in the choreic group.
Discussion
The main finding in the present study was that concentrations of NEFA in fasting plasma samples from patients with chorea were two-to four-fold those in control subjects. We have previously shown (Phillipson & Bird, 1976 ) that the mean fasting plasma growth hormone concentrations are raised in patients with Huntington's chorea. Abnormal growth hormone secretion has also been reported by other workers (Podolsky & Leopold, 1974; Leopold & Podolsky, 1975; Keogh, Johnson, Nanda & Sulaiman, 1976) . Growth hormone is known to cause the release of NEFA from peripheral fat depots (Raben & Hollenberg, 1959) . It therefore seems likely that the raised NEFA result at least in part from increased growth hormone secretion, although other factors such as adrenocorticotrophic hormone or circulating adrenaline, which are known to influence circulating NEFA, cannot be excluded. It is noteworthy that the differences in NEFA in choreic patients and control subjects disappear during the hyperglycaemic phase of the glucose tolerance test, and re-appear as plasma glucose concentrations return to normal (Fig. 2) . On the other hand, under hypoglycaemic conditions during the insulin tolerance tests, the difference between NEFA concentrations in control subjects and choreic patients is qualitatively and quantitatively maintained throughout the test. The responses to insulin are therefore in marked contrast to those obtained in the glucose tolerance test. It would seem therefore that the metabolic abnormalities resulting in increased circulating NEFA were corrected under hyperglycaemic conditions.
In our series of patients, there were no significant differences in plasma glucose responses in either the glucose tolerance test or the insulin provocation test when patients with Huntington's chorea were compared with control subjects. Podolsky, Leopold & Sax (1972) reported that in a sub-group of patients with Huntington's chorea there was an exaggerated increase in plasma glucose in response to oral glucose. Even when we removed from our group those patients who had the highest plasma glucose concentrations in this test there did not appear to be any difference from the control group. Furthermore, there was no correlation between duration of choreic symptoms and the maximum blood glucose concentrations. The reason for the difference in results is therefore not clear, but may be a result of patient selection. To establish this possibility, studies of much larger groups of choreic patients than the ten studied by Podolsky et al. (1972) , or the nine in our group, will be necessary.
The second main difference between control subjects and choreic patients in this study was the reduced free tryptophan concentrations in patients with Huntington's chorea (Fig. 4) . Other workers have previously reported small reductions in plasma tryptophan concentrations (Perry et al., 1969) . However, it is not certain with their method that only free tryptophan was being measured. It is clear from our results, however, that total tryptophan concentrations are normal in choreic patients and that only free tryptophan is reduced. The distribution of tryptophan in plasma, and in particular the equilibrium between tryptophan bound to plasma protein and free tryptophan, depends on several factors. Since free and bound tryptophan dissociate reversibly from plasma albumin according to the laws of mass action, there is a linear relation between the amount of free and bound tryptophan. This relation holds experimentally both in vitro and in vivo , provided that amounts of tryptophan added do not saturate the binding sites on the protein molecules. Since albumin is the chief site of tryptophan binding to plasma and since there appears to be only one binding site per molecule McMenamy & Oncley, 1958) , alterations in plasma albumin concentration may cause alterations in free tryptophan. Our results indicate, however, that plasma albumin concentrations are the same in choreic patients and in control subjects.
The concentration of NEFA has been shown to affect the degree of tryptophan binding to purified albumin preparations (McMenamy, 1965) and whole human plasma. When NEFA were added to human plasma at concentrations within the physiological range ) the amount of free tryptophan was increased; furthermore, in whole animals in which plasma NEFA were increased physiologically this was associated with increased free tryptophan concentrations (Knott & Curzon, 1972; and drugs affecting plasma NEFA also cause corresponding changes in free tryptophan concentrations (Curzon & Knott, 1974) . Thus there is a large body of evidence showing a correlation between physiologically induced changes in plasma NEFA and plasma free tryptophan. The correlation between reduced NEFA and reduced free tryptophan was shown to occur after oral glucose by Lipsett, Madras, Wurtman & Munroe (1973) . We con6rm this result in our glucose tolerance test both in patients with Huntington's chorea and control subjects and show in addition that the relationship also holds true in the insulin tolerance test (Fig. 4) . However, although it was expected that free tryptophan would be increased in choreic patients we found that the free tryptophan decreased. The reason for this puzzling result can be understood from Fig. 5 . Thus although choreic patients show, like control subjects, a significant positive correlation between plasma free tryptophan and NEFA, the slope of the line relating the two variables is altered such that, despite a high fasting concentration of NEFA in choreic patients, the free tryptophan concentration is reduced compared with control subjects. At low NEFA concentrations and at high plasma glucose concentrations these differences, however, tend to disappear. These results suggest that the normal equilibrium between free and bound tryptophan, and in particular its relation to plasma NEFA, is disturbed. One possibility is that the characteristics of tryptophan binding to the albumin molecule are abnormal. A second possibility, which we have been able to test, is that the transport of free tryptophan out of the plasma compartment, under conditions of raised NEFA concentrations, is abnormally rapid. Fernstrom & Wurtman (1972) proposed that one factor controlling tryptophan transport into brain was the concentrations of chiefly the branched-chain amino acids (leucine, isoleucine and valine), which compete for the same sites as tryptophan for uptake into brain. This view has gained support in other laboratories, for rats (Biggio et al., 1974; Gessa, Biggio, Fadda, Corsini & Tagliamonte, 1974) and man (PerezCruet, Chase & Murphy, 1974).
Thus, in brain, in the presence of lowered concentrations of the branched-chain amino acids it would be expected that tryptophan transport out of the plasma compartment would be increased and the amount of free tryptophan lowered. Since we have shown that concentrations of all three branchedchain amino acids are lowered, it is possible that this factor results in the lowered free tryptophan observed in choreic patients.
Huntington's chorea is frequently associated with increased appetite, increased food intake and weight loss. The patients appear, in some ways, to be starving. The biochemical features of starvation in man have been thoroughly studied. Among a wide range of biochemical changes there are prolonged increases in growth hormone output (Reichlin, 1973) , increases in plasma free fatty acids, which generate ketone acids necessary for use as the main oxidative fuel for the brain (Owen, Morgan, Kemp, Sullivan, Herrera & Cahill, 1967) , and reductions in plasma concentrations of leucine, isoleucine, valine and alanine (Felig, Owen, Wahren & Cahill, 1969 ). We have previously described increases in growth hormone secretion in choreic patients (Phillipson & Bird, 1976) , and Perry et al. (1969) have described reductions in plasma alanine, leucine, isoleucine and valine concentrations. Our present results show changes in plasma NEFA and confirm and extend Perry's observations on plasma amino acids. The similarity between a metabolic response to starvation and these results indicates the need for further study of this area.
